The Board of Directors of Aster DM Healthcare Limited will convene on January 30, 2026, to review and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Additionally, the board will consider the adoption of the Aster DM Healthcare Limited Employee Stock Option Scheme – 2026 (“ESOS 2026”).
Board Meeting Announcement
Aster DM Healthcare Limited has announced an upcoming meeting of its Board of Directors scheduled for January 30, 2026. Key items on the agenda include the review and approval of financial performance and consideration of a new employee stock option scheme.
Financial Results Discussion
The board will discuss and potentially approve the unaudited standalone and consolidated financial results for the fiscal quarter and nine-month period ending December 31, 2025. This includes a comprehensive review of the company’s financial standing and performance across its various business segments.
Consideration of ESOS 2026
A significant part of the meeting will be dedicated to the adoption of the Aster DM Healthcare Limited Employee Stock Option Scheme – 2026 (“ESOS 2026”). This scheme is designed in accordance with the Securities and Exchange Board of India regulations and aims to provide employee benefits and incentives.
Source: BSE
